AMNYPO
"AMNYPO" is a figurative mark owned by AstraZeneca UK Limited, filed at the EUIPO on August 19, 2022. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since January 10, 2023
- Filed
- August 19, 2022
- Registered
- January 6, 2023
- Expires
- August 19, 2032
- Application no.
- 018750228
- Registration no.
- 018750228
- Office
- EUIPO
- European Union Intellectual Property Office
- Mark type
- Figurative mark
- 1 class
Who owns AMNYPO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
What the mark covers
The products and services AMNYPO is filed for, grouped by Nice class.
Anti-cancer preparations; biological preparations for the treatment of cancer; chemical reagents for medical purposes; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for suppressing tumors; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; elixirs (pharmaceutical preparations)
What has happened so far
Steps recorded by the EUIPO, newest first.
- Bulletin 2026/178 Section C.2.2
- Bulletin 2026/135 Section C.1.3
- Bulletin 2023/005 Section B.1
- Bulletin 2022/182 Section A.1
About AMNYPO
Who owns the trademark "AMNYPO"?
The EUIPO trademark "AMNYPO" (application 018750228) is owned by AstraZeneca UK Limited.
What is the status of "AMNYPO"?
Its status at the EUIPO is: registered.
When was "AMNYPO" registered?
It was registered on January 6, 2023 and is due to expire on August 19, 2032.
Get this data via the API
Everything on this page comes from the Signa API. Pull AMNYPO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d43e7-dac1-75a6-80cb-d6389eb604fd
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d43e7-dac1-75a6-80cb-d6389eb604fd",
"object": "trademark",
"mark_text": "AMNYPO",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "EM",
"application_number": "018750228",
"filing_date": "2022-08-19",
"nice_classes": [
5
],
"owners": [
{
"name": "AstraZeneca UK Limited",
"entity_id": "ent_019eb6f8-0fa0-77ee-aa49-b354fdb26532"
}
]
}